Estimating an oncogenetic tree when false negatives and positives are presentSZABO, Aniko; BOUCHER, Kenneth.Mathematical biosciences. 2002, Vol 176, Num 2, pp 219-236, issn 0025-5564Article

Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve toleranceSHRIEVE, Dennis C; HAZARD, Lisa; BOUCHER, Kenneth et al.Journal of neurosurgery. 2004, Vol 101, pp 390-395, issn 0022-3085, 6 p., SUP3Article

Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS)SAMLOWSKI, Wolfram E; WATSON, Gordon A; WANG, Michael et al.Cancer. 2007, Vol 109, Num 9, pp 1855-1862, issn 0008-543X, 8 p.Article

A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluationAKERLEY, Wallace; BOUCHER, Kenneth; RICH, Nathan et al.Lung cancer. 2013, Vol 79, Num 3, pp 307-311, issn 0169-5002, 5 p.Article

Activated protein C resistance as measured by residual factor V after Russell's Viper Venom and activated protein C treatment analyzed as a continuous variable in multiple myeloma and normal controlsZANGARI, Maurizio; BERNO, Tamara; FENGHUANG ZHAN et al.Blood coagulation & fibrinolysis. 2011, Vol 22, Num 5, pp 420-423, issn 0957-5235, 4 p.Article

A Comparison of Colon and Rectal Somatic DNA AlterationsSLATTERY, Martha L; CURTIN, Karen; WOLFF, Roger K et al.Diseases of the colon & rectum. 2009, Vol 52, Num 7, pp 1304-1311, issn 0012-3706, 8 p.Article

Use of Oral N-Acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress: Towards a Novel Paradigm for Melanoma ChemopreventionGADELIYA GOODSON, Agnessa; COTTER, Murray A; CASSIDY, Pamela et al.Clinical cancer research (Print). 2009, Vol 15, Num 23, pp 7434-7440, issn 1078-0432, 7 p.Article

Sampling of melanocytic nevi for research purposes : A prospective, pilot study to determine effect on diagnosisFLORELL, Scott R; SMOLLER, Bruce R; BOUCHER, Kenneth M et al.Journal of the American Academy of Dermatology. 2008, Vol 59, Num 5, pp 814-821, issn 0190-9622, 8 p.Article

Serum Platelet Factor 4 Is an Independent Predictor of Survival and Venous Thromboembolism in Patients with Pancreatic AdenocarcinomaPORUK, Katherine E; FIRPO, Matthew A; HUERTER, Luke M et al.Cancer epidemiology, biomarkers & prevention. 2010, Vol 19, Num 10, pp 2605-2610, issn 1055-9965, 6 p.Article

Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltratesFLORELL, Scott R; CESSNA, Melissa; LUNDELL, Ryan B et al.American journal of clinical pathology. 2006, Vol 125, Num 5, pp 727-736, issn 0002-9173, 10 p.Article

Metabolic complications with the use of mTOR inhibitors for cancer therapySIVENDRAN, Shanthi; AGARWAL, Neeraj; GARTRELL, Benjamin et al.Cancer treatment reviews. 2014, Vol 40, Num 1, pp 190-196, issn 0305-7372, 7 p.Article

Improved Diagnosis of Pancreatic Adenocarcinoma Using Haptoglobin and Serum Amyloid A in a Panel Screen : Personalized Genomic Medicine and SurgeryFIRPO, Matthew A; GAY, David Z; GRANGER, Steven R et al.World journal of surgery. 2009, Vol 33, Num 4, pp 716-722, issn 0364-2313, 7 p.Conference Paper

Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastasesMAJER, Martin; JENSEN, Randy L; SHRIEVE, Dennis C et al.Cancer. 2007, Vol 110, Num 6, pp 1329-1337, issn 0008-543X, 9 p.Article

Longitudinal assessment of the nevus phenotype in a melanoma kindredFLORELL, Scott R; MEYER, Laurence J; ZONE, John J et al.Journal of investigative dermatology. 2004, Vol 123, Num 3, pp 576-582, issn 0022-202X, 7 p.Article